Prostate Artery Embolization
Sponsors
Saskatchewan Health Authority - Regina Area, Northwestern University, University of Minnesota, Merit Medical Systems, Inc., University of Mississippi Medical Center
Conditions
Benign Prostate HyperplasiaBenign Prostatic HyperplasiaBenign Prostatic Hyperplasia (BPH)Embolization, TherapeuticLower Urinary Tract SymptomsProstate HyperplasiaTransurethral Resection of Prostate Syndrome
Phase 2
Phase 3
Unknown Phase
Prostatic Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (BPH)
CompletedNCT02026908
Start: 2014-01-01End: 2023-03-27Updated: 2024-11-18
Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
CompletedNCT02930889
Start: 2016-10-01End: 2020-10-31Updated: 2021-12-02
Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres
CompletedNCT03052049
Start: 2017-09-06End: 2022-09-26Updated: 2023-10-10
Embosphere® PROstate Post Market Study
CompletedNCT03527589
Start: 2018-08-16End: 2022-01-22Updated: 2023-12-18
Prostate Artery Embolization: Single Center Experience
NCT04766268
Start: 2021-03-17End: 2023-04-10Target: 75Updated: 2022-02-24
Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE)
NCT05531240
Start: 2022-10-31End: 2025-12-31Target: 104Updated: 2022-10-03